Indian Pharmas, MNCs Eye Supreme Court Hearing On New Price-Cap Draft
This article was originally published in PharmAsia News
Executive Summary
Indian as well as multinational drug makers are expected to be watching closely Jan. 17 when the nation’s Supreme Court resumes hearing on government control of drugs considered “essential.”